No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer's disease in a UK cohort

Antonia Pritchard, David St Clair, Helen Lemmon, David M. A. Mann, Corinne Lendon

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Genome scans in sporadic Alzheimer's disease (AD) have revealed possible susceptibility loci on chromosome 12. Recently, two studies were published investigating the +1071 and +1073 polymorphisms in the lectin-like oxidised low density lipoprotein receptor (OLR1) gene with AD, a gene that lies within the area of chromosome 12 linkage. OLR1 is a good candidate gene, due to its function in lipid metabolism pathways, other components of which have been previously implicated as risk factors for AD. We undertook an association study in our UK cohort of 356 AD patients and 358 matched controls, using the same polymorphisms and performing the same sub-group and haplotype analysis as previously described. We found no association with AD in our case-control group as a whole, or when stratified into those with early (<65 years) or late (>65 years) onset. When the group was split into APOE 64 bearers and 64 non-bearers, we could not confirm the associations described in the original study. Similarly, no significant differences were observed between AD patients and controls, in terms of their haplotype distributions. Therefore, in this present study, we find no evidence for the involvement of these ORL1 polymorphisms in increasing susceptibility to AD. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)126-129
Number of pages4
JournalNeuroscience Letters
Volume366
Issue number2
DOIs
Publication statusPublished - Aug 2004

Fingerprint

Chromosomes, Human, Pair 12
LDL Receptors
Lectins
Alzheimer Disease
Genes
Haplotypes
oxidized low density lipoprotein
Lipid Metabolism
Genome
Control Groups

Keywords

  • Alzheimer's
  • chromosome 12
  • OLR1
  • association study
  • apolipoprotein-E
  • risk

Cite this

No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer's disease in a UK cohort. / Pritchard, Antonia; St Clair, David; Lemmon, Helen ; Mann, David M. A.; Lendon, Corinne.

In: Neuroscience Letters, Vol. 366, No. 2, 08.2004, p. 126-129.

Research output: Contribution to journalArticle

@article{6c0ea7f1f0fd49329b7b143268ceb2c8,
title = "No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer's disease in a UK cohort",
abstract = "Genome scans in sporadic Alzheimer's disease (AD) have revealed possible susceptibility loci on chromosome 12. Recently, two studies were published investigating the +1071 and +1073 polymorphisms in the lectin-like oxidised low density lipoprotein receptor (OLR1) gene with AD, a gene that lies within the area of chromosome 12 linkage. OLR1 is a good candidate gene, due to its function in lipid metabolism pathways, other components of which have been previously implicated as risk factors for AD. We undertook an association study in our UK cohort of 356 AD patients and 358 matched controls, using the same polymorphisms and performing the same sub-group and haplotype analysis as previously described. We found no association with AD in our case-control group as a whole, or when stratified into those with early (<65 years) or late (>65 years) onset. When the group was split into APOE 64 bearers and 64 non-bearers, we could not confirm the associations described in the original study. Similarly, no significant differences were observed between AD patients and controls, in terms of their haplotype distributions. Therefore, in this present study, we find no evidence for the involvement of these ORL1 polymorphisms in increasing susceptibility to AD. (C) 2004 Elsevier Ireland Ltd. All rights reserved.",
keywords = "Alzheimer's, chromosome 12, OLR1, association study, apolipoprotein-E, risk",
author = "Antonia Pritchard and {St Clair}, David and Helen Lemmon and Mann, {David M. A.} and Corinne Lendon",
year = "2004",
month = "8",
doi = "10.1016/j.neulet.2004.05.023",
language = "English",
volume = "366",
pages = "126--129",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer's disease in a UK cohort

AU - Pritchard, Antonia

AU - St Clair, David

AU - Lemmon, Helen

AU - Mann, David M. A.

AU - Lendon, Corinne

PY - 2004/8

Y1 - 2004/8

N2 - Genome scans in sporadic Alzheimer's disease (AD) have revealed possible susceptibility loci on chromosome 12. Recently, two studies were published investigating the +1071 and +1073 polymorphisms in the lectin-like oxidised low density lipoprotein receptor (OLR1) gene with AD, a gene that lies within the area of chromosome 12 linkage. OLR1 is a good candidate gene, due to its function in lipid metabolism pathways, other components of which have been previously implicated as risk factors for AD. We undertook an association study in our UK cohort of 356 AD patients and 358 matched controls, using the same polymorphisms and performing the same sub-group and haplotype analysis as previously described. We found no association with AD in our case-control group as a whole, or when stratified into those with early (<65 years) or late (>65 years) onset. When the group was split into APOE 64 bearers and 64 non-bearers, we could not confirm the associations described in the original study. Similarly, no significant differences were observed between AD patients and controls, in terms of their haplotype distributions. Therefore, in this present study, we find no evidence for the involvement of these ORL1 polymorphisms in increasing susceptibility to AD. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

AB - Genome scans in sporadic Alzheimer's disease (AD) have revealed possible susceptibility loci on chromosome 12. Recently, two studies were published investigating the +1071 and +1073 polymorphisms in the lectin-like oxidised low density lipoprotein receptor (OLR1) gene with AD, a gene that lies within the area of chromosome 12 linkage. OLR1 is a good candidate gene, due to its function in lipid metabolism pathways, other components of which have been previously implicated as risk factors for AD. We undertook an association study in our UK cohort of 356 AD patients and 358 matched controls, using the same polymorphisms and performing the same sub-group and haplotype analysis as previously described. We found no association with AD in our case-control group as a whole, or when stratified into those with early (<65 years) or late (>65 years) onset. When the group was split into APOE 64 bearers and 64 non-bearers, we could not confirm the associations described in the original study. Similarly, no significant differences were observed between AD patients and controls, in terms of their haplotype distributions. Therefore, in this present study, we find no evidence for the involvement of these ORL1 polymorphisms in increasing susceptibility to AD. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

KW - Alzheimer's

KW - chromosome 12

KW - OLR1

KW - association study

KW - apolipoprotein-E

KW - risk

U2 - 10.1016/j.neulet.2004.05.023

DO - 10.1016/j.neulet.2004.05.023

M3 - Article

VL - 366

SP - 126

EP - 129

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -